Rate of complications among the recipients of intrathecal baclofen pump in Japan: A multicenter study

Neuromodulation

Volumn 16, Issue 3, 2013, Pages 266-272

  Taira, Takaomi ^a   Ueta, Takayoshi ^b   Katayama, Yoichi ^c   Kimizuka, Mamori ^d   Nemoto, Akinobu ^e   Mizusawa, Hidehiro ^f   Liu, Meigen ^g   Koito, Motonao ^h   Hiro, Yuko ⁱ   Tanabe, Hirokazu ⁱ  

^a TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

^b SPINAL INJURIES CENTER   (Japan)

^c NIHON UNIVERSITY   (Japan)

^d National Rehabilitation Centre for Children with Disabilities   (Japan)

^e YOKOHAMA CITY UNIVERSITY   (Japan)

^f TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^g KEIO UNIVERSITY   (Japan)

^h Medtronic Japan Co Ltd   (Japan)

ⁱ DAIICHI SANKYO CO   (Japan)

Author keywords

Baclofen; complications; intrathecal drug delivery; spasticity; training course

Indexed keywords

BACLOFEN;

ADOLESCENT; ADULT; AGED; ARTICLE; CATHETER OCCLUSION; CHILD; FEMALE; FISTULA; FOLLOW UP; HUMAN; INFUSION RATE; INTRATHECAL PUMP; JAPAN; LIQUORRHEA; MAJOR CLINICAL STUDY; MALE; MENINGITIS; SCHOOL CHILD; SKIN ALLERGY; SPASTICITY; SURGICAL INFECTION;

ADOLESCENT; ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; BACLOFEN; CHILD; DRUG DELIVERY SYSTEMS; FEMALE; FOLLOW-UP STUDIES; HUMANS; INJECTIONS, SPINAL; JAPAN; MALE; MIDDLE AGED; MUSCLE RELAXANTS, CENTRAL; MUSCLE SPASTICITY; REGISTRIES; SURGICAL WOUND INFECTION; YOUNG ADULT;

EID: 84878534440     PISSN: 10947159     EISSN: 15251403     Source Type: Journal    
DOI: 10.1111/ner.12010     Document Type: Article

References (19)

1. Follett KA, Naumann CP,. A prospective study of catheter-related complications of intrathecal drug delivery systems. J Pain Symptom Manage 2000; 19: 209-215.
2. Coffey JR, Cahill D, Steers W, et al. Intrathecal baclofen for intractable spasticity of spinal origin: results of a long-term multicenter study. J Neurosurg 1993; 78: 226-232.
3. Delhaas EM, Beersen N, Redekop WK, Klazinga NS,. Long-term outcomes of continuous intrathecal baclofen infusion for treatment of spasticity: a prospective multicenter follow-up study. Neuromodulation 2008; 11: 227-236.
4. Vidal J, Fenollosa P, Martin E, et al. Safety and efficacy of intrathecal baclofen infusion by implantable pump for the treatment of severe spinal spasticity: a Spanish multicenter study. Neuromodulation 2000; 3: 175-182.
5. Plassat R, Perrouin Verbe B, Menei P, Menegalli D, Mathe JF, Richard I,. Treatment of spasticity with intrathecal baclofen administration: long-term follow-up, review of 40 patients. Spinal Cord 2004; 42: 686-693.
6. Nielsen JF, Hansen HJ, Sunde N, Christensen JJ,. Evidence of tolerance to baclofen in treatment of severe spasticity with intrathecal baclofen. Clin Neurol Neurosurg 2002; 104: 142-145.
7. Guillaume D, Van Havenbergh A, Vloeberghs M, Vidal J, Roeste G,. A clinical study of intrathecal baclofen using a programmable pump for intractable spasticity. Arch Phys Med Rehabil 2005; 86: 2165-2171.
8. Ivanhoe CB, Francisco GE, McGuire JR, Subramanian T, Grissom SP,. Intrathecal baclofen management of poststroke spastic hypertonia: implications for function and quality of life. Arch Phys Med Rehabil 2006; 87: 1509-1515.
9. Motta F, Buonaguro V, Stignani C,. The use of intrathecal baclofen pump implants in children and adolescents: safety and complications in 200 consecutive cases. J Neurosurg 2007; 107 (1 Suppl.): 32-35.
10. Vender JR, Hester S, Waller JL, Rekito A, Lee MR,. Identification and management of intrathecal baclofen pump complications: a comparison of pediatric and adult patients. J Neurosurg 2006; 104 (1 Suppl.): 9-15.
11. Ordia JI, Fischer E, Adamski E, Chagnon KG, Spatz EL,. Continuous intrathecal baclofen infusion by a programmable pump in 131 consecutive patients with severe spasticity of spinal origin. Neuromodulation 2002; 5: 16-24.
12. Penn RD, York MM, Paice JA,. Catheter systems for intrathecal drug delivery. J Neurosurg 1995; 83: 215-217.
13. Haranhalli N, Anand D, Wisoff JH, et al. Intrathecal baclofen therapy: complication avoidance and management. Childs Nerv Syst 2011; 27: 421-427.
14. Penn RD,. Intrathecal baclofen for spasticity of spinal origin: seven years of experience. J Neurosurg 1992; 77: 236-240.
15. Ordia JI, Fischer E, Adamski E, Spatz EL,. Chronic intrathecal delivery of baclofen by a programmable pump for the treatment of severe spasticity. J Neurosurg 1996; 85: 452-457.
16. Heetla HW, Staal MJ, Kliphuis C, van, Laar T,. The incidence and management of tolerance in intrathecal baclofen therapy. Spinal Cord 2009; 47: 751-756.
17. Albright AL, Barron WB, Fasick MP, Polinko P, Janosky J,. Continuous intrathecal baclofen infusion for spasticity of cerebral origin. JAMA 1993; 270: 2475-2477.
18. Stetkarova I, Yablon SA, Kofler M, Stokic DS,. Procedure- and device-related complications of intrathecal baclofen administration for management of adult muscle hypertonia: a review. Neurorehabil Neural Repair 2010; 24: 609-619.
19. Albright AL, Turner M, Pattisapu JV,. Best-practice surgical techniques for intrathecal baclofen therapy. J Neurosurg 2006; 104 (4 Suppl.): 233-239.